Fig. 1: Kaplan–Meier estimates of cumulative rates of suppression of plasma HIV RNA within the entire cohort of 1422 patients who initiated highly active antiretroviral therapy (HAART) during the study period (at left) and within the subpopulation of 816 patients who were defined as adherent (at right), according to history of injection drug use.